Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine,Immunology,Immunology and Allergy
Reference16 articles.
1. Eric S, Thomas B, Emma G, Lisa B, Andrew B, Michael C, et al. Two phases 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375:2335–48.
2. Fleur B, Daphne B, Inge H, Lieneke A, Jorien S, Marijke D, et al. Dupilumab facial redness: positive effect of itraconazole. J Am Acad Dermatol Case Rep. 2019;5(10):888–91.
https://doi.org/10.1016/j.jdcr.2019.07.020
.
3. Waldman R, DeWane M, Sloan B, Grant J. Characterizing dupilumab facial redness: a multi-institution retrospective medical record review. J Am Acad Dermatol. 2020;82(1):230–2.
4. Dalia Y, Marchese S. Case report: first reported case of facial rash after Dupilumab therapy, Call for abstracts. Practical Dermatology.
https://practicaldermatology.com/articles/2018-apr/case-report-first-reported-case-of-facial-rash-after-dupilumab-therapy-call-for-abstracts
. Accessed May 3, 2019.
5. Michelle P, Ana O, Graciela A, Caroline G, Joan M, Paul F, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64:2677–86.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献